Publicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (11)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2022

  1. Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort

    Neuro-oncology, Vol. 24, Núm. 10, pp. 1726-1735

2021

  1. MHC Class II antigen presentation by lymphatic endothelial cells in tumors promotes intratumoral regulatory T cell-suppressive functions

    Cancer Immunology Research, Vol. 9, Núm. 7, pp. 748-764

2020

  1. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma

    PLoS ONE, Vol. 15, Núm. 9 September

  2. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

2018

  1. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

    Nature Communications, Vol. 9, Núm. 1

2016

  1. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477

2014

  1. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and hedgehog signaling activation

    Cancer Research, Vol. 74, Núm. 13, pp. 3512-3524

2011

  1. Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer

    Liver International, Vol. 31, Núm. 10, pp. 1542-1553

1995

  1. Immunocytochemical localization of a vacuolar-type ATPase in Malpighian tubules of the ant Formica polyctena

    Cell & Tissue Research, Vol. 282, Núm. 2, pp. 343-350